Table 3.
Predictors of work and school absenteeism in the study cohort (n=107)
| Variables | B | SE | OR | 95% CI | P | |
|---|---|---|---|---|---|---|
| Lower | Upper | |||||
| Gender | −0.010 | 0.46 | 0.99 | 0.41 | 2.44 | 0.98 |
| Age category (years) | ||||||
| 0-18 | ||||||
| 19-40 | ||||||
| 41-60 | −0.193 | 0.36 | 0.83 | 0.41 | 1.66 | 0.59 |
| Family history of IBD | 1.467 | 0.88 | 4.34 | 0.77 | 24.43 | 0.09 |
| IBD subtypes | 1.309 | 0.48 | 3.70 | 1.45 | 9.46 | 0.006* |
| Crohn’s disease | ||||||
| Ulcerative colitis | ||||||
| Perianal disease | 1.982 | 0.90 | 7.26 | 1.24 | 42.33 | 0.028* |
| Extraintestinal manifestations | 1.171 | 0.60 | 3.23 | 0.99 | 10.48 | 0.05 |
| Thiopurines | 0.409 | 0.57 | 1.51 | 0.49 | 4.57 | 0.47 |
| Adalimumab | −0.154 | 0.59 | 0.86 | 0.27 | 2.72 | 0.79 |
| Infliximab | −0.671 | 0.69 | 0.51 | 0.13 | 1.97 | 0.33 |
| Colectomy | 0.254 | 1.07 | 1.29 | 0.16 | 10.51 | 0.81 |
| Small bowel resection | −0.184 | 2.18 | 0.84 | 0.01 | 59.34 | 0.93 |
*P<0.05. IBD – Inflammatory bowel disease; SE – Standard error; OR – Odds ratio; CI – Confidence interval